N/A N=20 Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)
Solid Neoplasms With NTRK Fusions
Primary: Duration of Response (DoR) — 24.5 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=13 Genistein in Treatment of Metastatic Colorectal Cancer
Colon Cancer · Rectal Cancer · Colorectal Cancer
Primary: Number of Adverse Events — 250; 119; 24; 0 events
N/A N=50 Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Health Behavior · Colorectal Cancer · Influenza
Primary: Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms — 17; 8 Participants
Phase 2 N=77 Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
Peripheral T Cell Lymphoma · PTCL · Extranodal NK/T-cell Lymphoma
Primary: Overall Response Rate (ORR) — 31.8; 20.5; 45.5 Percentage of participants
Phase 2 N=30 Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
Blasts 10 Percent or More of Bone Marrow Nucleated Cells · Chronic Myelomonocytic Leukemia-2 · High Grade Malignant Neoplasm
Primary: Feasibility of Early Allogeneic Hematopoietic Cell Transplant Assessed by Enrollment and Incidence of Early Transplant — 9; 21 Participants
N/A N=128 A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
Colorectal Cancer
Primary: Percentage of Participants Who Received a Colorectal Cancer Screening Test — 2; 2 Participants
Phase 2 N=24 Trial of Aspirin and Arginine Restriction in Colorectal Cancer
Colorectal Cancer
Primary: Rectal Tissue Putrescine Reduction — 17 Participants
Phase 2 N=141 Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Colorectal Adenomatous Polyps
Primary: Rectal Epithelial Cell Proliferation — 19.3; 20.3; 18.9; 16.8 percentage of cells positive
N/A N=115 Test Up Now Education Program
Colorectal Cancer Screening
Primary: Number of Participants Up to Date on Colorectal Cancer Screening — 29; 31 Participants — p=<0.05
N/A N=20 Virtual Reality for Improving Pain and Distress in Patients With Advanced Stage Colorectal Cancer
Colorectal Cancer
Primary: Feasibility, Assessed by Examining Number of Participants Accrued — 20 Participants
Phase 2 N=63 Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
Colorectal Cancer
Primary: Median Time for Progression Free Survival — 15.8 Months
Phase 3 N=410 Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
Venous Thromboembolism
Primary: Number of Participants With Postoperative VTE Within 48 Hours After Surgery — 5; 3 participants — p=0.72
N/A N=239 Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
Colorectal Cancer · Hereditary Non-polyposis Colon Cancer
Primary: Impact of Standard Informed Consent vs CD-ROM Educational Intervention on Knowledge About Microsatellite Instability (MSI) Testing — 4.07; 4.17 units on a scale
N/A N=1,855 The Colorectal Breath Analysis (COBRA) Study
Colorectal Cancer · Colorectal Polyps · Colorectal Adenocarcinoma
Primary: Determine the Diagnostic Accuracy of the Proposed Breath Test for Detection of Colorectal Cancer in All Patients — 79; 86 percentage of true cases
N/A N=921 Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients
Colorectal Cancer Screening
Primary: Number (and Proportion) of Participants Who Request a Colorectal Cancer (CRC) Screening Test — 16; 17; 22; 19 Participants